Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 43 (6) , 1017-1023
- https://doi.org/10.1067/mjd.2000.108369
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Do patients with systemic sclerosis have abnormal gallbladder function?European Journal of Gastroenterology & Hepatology, 1997
- The use of serologic markers for collagen synthesis and degradation in systemic sclerosisJournal of the American Academy of Dermatology, 1995
- Localized scleroderma-response to 1,25-dihydroxyvitamin D3Clinical and Experimental Dermatology, 1990
- Systemic sclerosis: is there a treatment yet?Annals of the Rheumatic Diseases, 1990
- A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasisJournal of the American Academy of Dermatology, 1988
- 1,25-Dihydroxyvitamin D 3 : a Novel Immunoregulatory HormoneScience, 1984
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).Journal of Clinical Investigation, 1976
- Scleroderma and the Subcutaneous TissueScience, 1971
- Collagen Fibrils of the Scleroderma in Ultra-thin Skin SectionsNature, 1964